TCP10L
Basic information
Region (hg38): 21:32497967-32587373
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the TCP10L gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 9 | |||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 1 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 9 | 0 | 1 |
Variants in TCP10L
This is a list of pathogenic ClinVar variants found in the TCP10L region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
21-32501436-C-T | not specified | Uncertain significance (Sep 14, 2022) | ||
21-32503926-G-A | not specified | Uncertain significance (May 24, 2024) | ||
21-32503934-T-G | not specified | Uncertain significance (Jul 08, 2022) | ||
21-32504009-A-G | not specified | Uncertain significance (Jul 20, 2022) | ||
21-32514809-T-C | Benign (Jun 01, 2018) | |||
21-32514843-G-A | not specified | Uncertain significance (Mar 01, 2024) | ||
21-32514918-C-A | not specified | Uncertain significance (Jan 04, 2022) | ||
21-32514918-C-T | Likely benign (Dec 01, 2022) | |||
21-32514921-G-A | not specified | Uncertain significance (Jul 20, 2022) | ||
21-32515036-C-G | not specified | Uncertain significance (Jul 25, 2023) | ||
21-32515045-G-A | not specified | Uncertain significance (Dec 14, 2021) | ||
21-32515045-G-T | Benign (Jun 01, 2018) | |||
21-32515079-A-T | not specified | Uncertain significance (Aug 02, 2022) | ||
21-32515127-G-T | not specified | Uncertain significance (May 23, 2024) | ||
21-32515173-A-G | Benign (Jul 16, 2018) | |||
21-32576780-A-AC | Benign (Jan 22, 2018) | |||
21-32576787-C-G | not specified | Uncertain significance (Jan 22, 2024) | ||
21-32576842-G-A | not specified | Uncertain significance (Jan 26, 2023) | ||
21-32578767-T-A | not specified | Uncertain significance (Jan 18, 2023) | ||
21-32582229-G-C | not specified | Uncertain significance (Jun 10, 2024) | ||
21-32582314-C-G | not specified | Uncertain significance (Jan 08, 2024) | ||
21-32582333-C-T | not specified | Uncertain significance (Mar 25, 2024) | ||
21-32582340-T-C | not specified | Uncertain significance (Mar 29, 2023) | ||
21-32582391-G-A | not specified | Uncertain significance (Jun 30, 2022) | ||
21-32584189-G-A | not specified | Uncertain significance (Feb 28, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
TCP10L | protein_coding | protein_coding | ENST00000300258 | 4 | 10822 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.00330 | 0.841 | 125701 | 0 | 45 | 125746 | 0.000179 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.0641 | 122 | 124 | 0.984 | 0.00000681 | 1378 |
Missense in Polyphen | 39 | 37.712 | 1.0342 | 474 | ||
Synonymous | 0.384 | 44 | 47.4 | 0.929 | 0.00000287 | 430 |
Loss of Function | 1.18 | 5 | 8.78 | 0.569 | 4.59e-7 | 94 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00120 | 0.00120 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000163 | 0.000163 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000881 | 0.0000879 |
Middle Eastern | 0.000163 | 0.000163 |
South Asian | 0.000131 | 0.000131 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: May be involved in transcriptional regulation. Has in vitro transcription inhibition activity. Acts as a tumor suppressor in hepatocellular carcinoma (HCC) cells. {ECO:0000269|PubMed:14586771, ECO:0000269|PubMed:24565846}.;
Recessive Scores
- pRec
- 0.0535
Intolerance Scores
- loftool
- 0.749
- rvis_EVS
- 0.15
- rvis_percentile_EVS
- 64.51
Haploinsufficiency Scores
- pHI
- 0.0374
- hipred
- N
- hipred_score
- 0.112
- ghis
- 0.449
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.111
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Gene ontology
- Biological process
- negative regulation of transcription by RNA polymerase II
- Cellular component
- nucleus
- Molecular function
- transcription corepressor activity;protein binding;identical protein binding;protein self-association;repressing transcription factor binding